Cancer Screening Decision Assistance Tool (CDSS)
Earlier conversations. Better-targeted screening decisions. In collaboration with your health professional.
Available only through participating physicians in authorized UAE clinical settings. Canada and U.S. clinical availability is pending Health Canada and FDA review.
Clinical availability: BioTwin's cancer screening decision-assistance pathway is available only through participating physicians in authorized UAE clinical settings. Canada and U.S. clinical availability is pending Health Canada and FDA review. TwinMe is BioTwin's non-medical wellness experience.
What it is
BioTwin's Cancer Screening Decision Assistance Tool (CDSS) is a clinical screening decision-assistance tool for authorized physician-led settings. It is not a standalone screening test and it is not a standalone diagnostic device. It supports earlier and better-targeted screening conversations between patients and licensed healthcare professionals in authorized clinical settings by giving them novel longitudinal information about biology.
How it works
BioTwin combines biomarker-derived metabolic signals from Bio-Signature kits, wearable signals, lifestyle data, and history into a structured screening decision-assistance profile for authorized clinical pathways. The profile is shared only within authorized clinical workflows. Licensed healthcare professionals decide, based on their clinical judgment and local standards, whether further screening is appropriate.
How BioTwin works with your health professional
BioTwin is not, and never will be, an expert in oncology. BioTwin's role is to provide novel longitudinal information that your health professional does not otherwise have access to. The clinical decision always remains with your health professional.
Where it is approved
UAE: available through participating physicians in authorized clinical settings. Canada: pending Health Canada review. United States: pending FDA review.
Important boundaries
The CDSS is a clinical screening decision-assistance tool for authorized physician-led settings. It is not a standalone screening test and it is not a standalone diagnostic device. It does not replace clinical judgment, screening, or diagnosis. Treatment and diagnosis decisions remain with licensed healthcare professionals.
For specific questions, contact BioTwin.